Come up with a name for your new list and we'll add to it:
OncoNano Medicine raised a round of funding on August 28, 2014. Investors include
Cancer Prevention and Research Institute of Texas.
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple and effective identifier of disea…